Table 3.

Comparison of subgroup characteristics

	Conservative therapy (N = 20)	Failed conservative therapy (N = 9)	p-value	No redislocation (N = 23)	Redislocation (N = 6)	p-value
Patient characteristics
Age at time of initial dislocation	42 ± 11.4	36.3 ± 18	n.s.	41.4 ± 11.2	35.8 ± 21.7	n.s.
Follow-up, mean ± SD, months	106.1 ± 33.2	81.9 ± 23.6	n.s.	100.6 ± 34.0	90.7 ± 24.6	n.s.
Sex
Male, N (%)	18 (90)	6 (67)	n.s.	20 (87)	4 (67)	n.s.
Female, N (%)	2 (10)	3 (33)		3 (13)	2 (33)
Affected side
Right side, N (%)	7 (35)	3 (33)	n.s.	7 (30)	3 (50)	n.s.
Left side, N (%)	11 (55)	6 (67)		14 (61)	3 (50)
Both sides, N (%)	1 (10)	0 (0)		1 (9)	0 (0)
Dominant side, N (%)	10 (50)	3 (33)	n.s.	10 (44)	3 (50)	n.s.
Non-dominant side, N (%)	10 (50)	6 (67)		13 (56)	3 (50)
Beighton-Score, mean ± SD	1.2 ± 1.2	1.4 ± 1.9	n.s.	1.3 ± 1.4	1 ± 1.4	n.s.
SSA-Score, mean ± SD	6.2 ± 2.1	6.3 ± 2.9	n.s.	6 ± 2.2	7 ± 3	n.s.
Posttraumatic radiological parameters
Alpha angle, mean ± SD	43.3 ± 5.9	46.1 ± 8.6	n.s.	43.8 ± 6.8	45.6 ± 7.4	n.s.
Beta angle, mean ± SD	48.4 ± 8.6	47.3 ± 11.1	n.s.	48.5 ± 8.7	46.3 ± 12.1	n.s.
Gamma angle, mean ± SD	91.7 ± 9.5	93.4 ± 5.9	n.s.	92.3 ± 9	91.9 ± 6.6	n.s.
Adapted gamma angle, mean ± SD	93.3 ± 9.7	97,8 ± 7,2	n.s.	94.4 ± 10.2	96.0 ± 2.9	n.s.
Depth of RHSL, mean ± SD, %	15.2 ± 5.3	11.2 ± 2.3	0.01	14.6 ± 5.2	11.3 ± 2.5	n.s.
Glenoid defect area, mean-area ± SD, %	1.6 ± 1.9	4.1 ± 6.6	n.s.	1.9 ± 2.9	4 ± 7.1	n.s.
Glenoid defect diameter, mean-diameter ± SD, mm	0.7 ± 1.5	1.9 ± 2.8	n.s.	0.9 ± 1.9	1.8 ± 2.6	n.s.
Glenohumeral centring, mean ± SD, %	50.6 ± 6.6	58.2 ± 11.8	n.s.	50.6 ± 6.4	61.9 ± 12.5	n.s.
Glenoid version, mean ± SD	8.2 ± 3.6	8.7 ± 2.8	n.s.	8.2 ± 3.4	8.8 ± 3.4	n.s.
Scapulohumeral centring, mean ± SD, %	58.8 ± 6.0	63.0 ± 10.9	n.s.	59.3 ± 6.3	63.4 ± 12.7	n.s.

SSA-Score subjective shoulder activity-score, RHSL reverse Hill–Sachs lesion